Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Stem Cell Therapy for Multiple Sclerosis Publisher



Rahim F1 ; Arjmand B2 ; Tirdad R3 ; Saki Malehi A4
Authors

Source: Cochrane Database of Systematic Reviews Published:2018


Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the benefits and the harms of stem cell therapy for reducing the activity and severity of the disease in people with multiple sclerosis. © 2018 The Cochrane Collaboration.
Related Docs
View other Related Docs
1. Current Advances in Stem Cell Therapy in the Treatment of Multiple Sclerosis, Reviews in the Neurosciences (2023)
2. Stem Cell Therapy ‒Approach for Multiple Sclerosis Treatment, Archives of Neuroscience (2016)
3. Mechanisms and Potentials of Stem Cells in the Treatment of Multiple Sclerosis: The Unpaved Path, Multiple Sclerosis: A Mechanistic View (2016)
Experts (# of related papers)
View all Related Experts
Mohammad Ali Sahraian (3)
Babak Arjmand (3)
Other Related Docs
4. Recent Advances in Mesenchymal Stem Cell Therapy for Multiple Sclerosis: Clinical Applications and Challenges, Frontiers in Cell and Developmental Biology (2025)
5. Therapeutic Use of Intrathecal Mesenchymal Stem Cells in Patients With Multiple Sclerosis: A Pilot Study With Booster Injection, Immunological Investigations (2019)
6. Immunomodulatory Characteristics of Mesenchymal Stem Cells and Their Role in the Treatment of Multiple Sclerosis, Cellular Immunology (2015)
7. Autologous Hematopoietic Stem-Cell Transplantation in Multiple Sclerosis: A Systematic Review and Meta-Analysis, Neurology and Therapy (2022)
8. Osteopontin (Opn) As a Csf and Blood Biomarker for Multiple Sclerosis: A Systematic Review and Meta-Analysis, PLoS ONE (2018)
9. Mesenchymal Stem Cells for Multiple Sclerosis (Mesems): A Randomized, Double Blind, Cross-Over Phase I/Ii Clinical Trial With Autologous Mesenchymal Stem Cells for the Therapy of Multiple Sclerosis, Trials (2019)
10. The Effectiveness of Telehealth Interventions for People With Multiple Sclerosis: A Systematic Review and Meta-Analysis Protocol, Digital Health (2023)
11. Fluoxetine for Multiple Sclerosis, Cochrane Database of Systematic Reviews (2018)
12. Standard Operating Procedure for the Good Manufacturing Practice-Compliant Production of Human Endometrial Stem Cells for Multiple Sclerosis, Methods in Molecular Biology (2021)
13. Efficacy and Safety of Peginterferon Beta-1A Compared to Interferon Beta-1A in Relapsing Remitting Multiple Sclerosis Patients: A Phase 3, Randomized, Non-Inferiority Clinical Trial (Pegintegrity), Multiple Sclerosis and Related Disorders (2024)
14. Emerging Stem Cell Therapy and Tissue Engineering-Based Approaches in Neurodegenerative Diseases, Handbook of Stem Cell Applications (2024)
15. Stem Cell-Based Approach for the Treatment of Parkinson's Disease, Medical Journal of the Islamic Republic of Iran (2015)
16. The Effects of Omega-3 Supplementation on the Expanded Disability Status Scale and Inflammatory Cytokines in Multiple Sclerosis Patients: A Systematic Review and Meta-Analysis, CNS and Neurological Disorders - Drug Targets (2019)
17. Post Marketing New Adverse Effects of Oral Therapies in Multiple Sclerosis: A Systematic Review, Multiple Sclerosis and Related Disorders (2022)
18. Safety and Effectiveness of Cinnomer® on Disease Characteristics, Depression, and Quality of Life of Patients With Multiple Sclerosis: A Phase Iv, Post-Marketing, Prospective, Multicenter Study, Archives of Iranian Medicine (2023)
19. Self-Management Interventions For People With Multiple Sclerosis: A Systematic Review and Meta-Analysis Protocol, Health Science Reports (2023)
20. Identification of the Most Cost-Saving Disease-Modifying Therapies and Factors Affecting the Budget in the Pharmacotherapy of Multiple Sclerosis: A Systematic Review, European Journal of Clinical Pharmacology (2025)